University of Kansas Cancer Center receives $4.2M from NCI to research breast cancer chemoprevention

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Researchers at the University of Kansas Cancer Center have received a $4.2 million, five-year grant from NCI to study the effects of bazedoxifene and low-dose conjugated estrogen in women who are at increased risk for developing breast cancer and are experiencing menopausal symptoms. 

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Table of Contents